[Source: GenomeWeb News] — High Throughput Genomics said today that it has signed an agreement with Clinical Reference Laboratory Global Services under which it will perform lab services for HTG’s clients.
CRL Global Services provides testing for toxicology, molecular diagnostics, bioanalytics, and clinical trials. Under the deal, it will evaluate samples or sample plates using HTG’s quantitative nuclease protection assay ArrayPlate technology and reagent kits.
HTG’s automated qNPA technology measures gene expression levels of mRNA and miRNA in cells, blood, saliva, and tissues.
CRL Global Services will start offering its services to HTG clients through its CLIA-certified molecular diagnostics lab beginning this spring.
For more information click here.